Oxidative stress and steatosis are cofactors of liver injury in primary biliary cirrhosis

Journal of Gastroenterology

Volumn 45, Issue 10, 2010, Pages 1053-1062

  Sorrentino, Paolo ^a,c   Terracciano, Luigi ^b   D'Angelo, Salvatore ^a   Ferbo, Umberto ^a   Bracigliano, Alessandra ^c   Tarantino, Luciano ^d   Perrella, Alessandro ^c,e   Perrella, Oreste ^f   De Chiara, Giovanni ^a   Panico, Luigi ^a,c   De Stefano, Noè ^a   Lepore, Mariolina ^a,c   Vecchione, Raffaela ^c  

^a S G MOSCATI HOSPITAL   (Italy)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d SAN GIOVANNI DI DIO HOSPITAL   (Italy)

^e CARDARELLI HOSPITAL   (Italy)

^f AO Dei Colli Hospital for Infectious Diseases D Cotugno   (Italy)

Author keywords

Alcohol; Autoimmune cholangitis; BMI; Iron; Lipid peroxidation; Obesity; Oxidative stress; Primary biliary cirrhosis; Steatosis

Indexed keywords

HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G; MALONALDEHYDE; MITOCHONDRION ANTIBODY;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ANTIBODY TITER; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETES MELLITUS; FATTY LIVER; FEMALE; HUMAN; IMMUNITY; IMMUNOREACTIVITY; LIPID PEROXIDATION; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OBESITY; OXIDATIVE STRESS; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ALCOHOL DRINKING; ANTIBODIES; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FATTY LIVER; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIPID PEROXIDATION; LIVER CIRRHOSIS, BILIARY; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; OXIDATIVE STRESS; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 78249232939     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-010-0249-x     Document Type: Article

References (65)

1. M Sasaki H Ikeda Y Nakanuma 2008 Activation of ATM signaling pathway is involved in oxidative stress-induced expression of mito-inhibitory p21WAF1/Cip1 in chronic non-suppurative destructive cholangitis in primary biliary cirrhosis: an immunohistochemical study J Autoimmun 31 73 78 10.1016/j.jaut.2008.03.005 18456456 1:CAS:528:DC%2BD1cXmtlSiur4%3D
2. G Poli 2000 Pathogenesis of liver fibrosis: role of oxidative stress Mol Aspects Med 21 49 98 10.1016/S0098-2997(00)00004-2 10978499 1:CAS:528: DC%2BD3cXmt1Sgu74%3D (Pubitemid 30642764)
3. A Suriawinata MI Fiel 2004 Liver pathology in obesity Semin Liver Dis 24 363 370 10.1055/s-2004-860865 15605304 (Pubitemid 40052627)
4. G Leandro A Mangia J Hui P Fabris L Rubbia-Brandt G Colloredo, et al. 2006 HCV Meta-Analysis (on) Individual Patients' Data Study Group. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data Gastroenterology 130 1636 1642 10.1053/j.gastro.2006.03.014 16697727
5. R Rolla D Vay E Mottaran M Parodi N Traverso S Aricó M Sartori, et al. 2000 Detection of circulating antibodies against malondialdehyde- acetaldehyde adducts in patients with alcohol-induced liver disease Hepatology. 31 878 884 10.1053/he.2000.5373 10733543 1:CAS:528:DC%2BD3cXis1Cksrk%3D
6. E Albano E Mottaran M Vidali E Reale S Saksena G Occhino, et al. 2005 Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis Gut 54 987 993 10.1136/gut.2004.057968 15951547 1:CAS:528:DC%2BD2MXmsFKqtr0%3D (Pubitemid 40873914)
7. M Vidali MF Tripodi A Ivaldi R Zampino G Occhino L Restivo, et al. 2008 Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C J Hepatol 48 399 406 10.1016/j.jhep.2007.10.011 18164507 1:CAS:528:DC%2BD1cXhsl2msrs%3D
8. DJ Tuma 2002 Role of malondialdehyde-acetaldehyde adducts in liver injury Free Radic Biol Med 15 32 303 308 10.1016/S0891-5849(01)00742-0 (Pubitemid 34159083)
9. GM Thiele DJ Tuma MS Willis JA Miller TL McDonald MF Sorrell, et al. 1998 Soluble proteins modified with acetaldehyde and malondialdehyde are immunogenic in the absence of adjuvant Alcohol Clin Exp Res 22 1731 1739 9835288 1:CAS:528:DyaK1cXnvFOiurc%3D
10. C Rigamonti E Mottaran E Reale R Rolla V Cipriani F Capelli, et al. 2003 Moderate alcohol consumption increases oxidative stress in patients with chronic hepatitis C Hepatology. 38 42 49 10.1053/jhep.2003.50275 12829985 1:CAS:528:DC%2BD3sXlvFajurg%3D (Pubitemid 36775794)
11. LM Fletcher JL Dixon DM Purdie LW Powell DH Crawford 2002 Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis Gastroenterology 122 281 289 10.1053/gast.2002.30992 11832443
12. Searle JW, Kerr JFR, Halliday JW, Powell LW. Iron storage disease. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. 3rd ed. Edinburgh: Churchill Livingstone; 1994. p. 257-72.
13. Portmann BC, Nakanuma Y. Disease of the bile duct. In: MacSween RNM, Anthony PP, Scheuer PJ, editors. Pathology of the liver. 3rd ed. Edinburgh: Churchill Livingstone; 1994. p. 435-506.
14. O Chazouilleres D Wendum L Serfaty S Montembault O Rosmorduc R Poupon 1998 Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy Hepatology 28 296 301 10.1002/hep.510280203 9695990 1:CAS:528:DyaK1cXlsFGgu7c%3D (Pubitemid 28363652)
15. MM Kaplan ME Gershwin 2005 Primary biliary cirrhosis N Engl J Med 353 1261 1273 10.1056/NEJMra043898 16177252 1:CAS:528:DC%2BD2MXhtVeltLbI (Pubitemid 41345948)
16. N Alptekin G Mehmetçik M Uysal G Aykaç-toker 1997 Evidence for oxidative stress in the hepatic mitochondria of bile duct ligated rats Pharmacol Res 36 243 247 10.1006/phrs.1997.0225 9367670 1:CAS:528: DyaK2sXnvVWmtL4%3D (Pubitemid 27480724)
17. G Karadeniz S Acikgoz IO Tekin O Tascýlar BD Gun M Cömert 2008 Oxidized low-density-lipoprotein accumulation is associated with liver fibrosis in experimental cholestasis Clinics (Sao Paulo) 63 531 540
18. M Cömert IO Tekin S Acikgöz Y Ustündaǧ BH Uçan Z Acun, et al. 2004 Experimental bile-duct ligation resulted in accumulation of oxidized low-density lipoproteins in BALB/c mice liver J Gastroenterol Hepatol 19 1052 1057 10.1111/j.1440-1746.2004.03400.x 15304124 (Pubitemid 39237441)
19. MR Teli CP Day AD Burt MK Bennett OF James 1995 Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver Lancet 346 987 990 10.1016/S0140-6736(95)91685-7 7475591 1:STN:280:DyaK28%2FhtFCjtQ%3D%3D
20. LE Adinolfi M Gambardella A Andreana MF Tripodi R Utili G Ruggiero 2001 Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 1358 1364 10.1053/jhep.2001.24432 11391523 1:STN:280: DC%2BD3MzhvFajsA%3D%3D (Pubitemid 32496971)
21. EE Powell WG Cooksley R Hanson J Searle JW Halliday LW Powell 1990 The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 74 80 10.1002/hep.1840110114 2295475
22. SH Caldwell DM Crespo 2004 The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease J Hepatol 40 578 584 10.1016/j.jhep.2004.02.013 15030972 (Pubitemid 38367778)
23. J Wyatt H Baker P Prasad YY Gong C Millson 2004 Steatosis and fibrosis in patients with chronic hepatitis C J Clin Pathol 57 402 406 10.1136/jcp.2003. 009357 15047745 1:STN:280:DC%2BD2c7lsVOjtg%3D%3D (Pubitemid 38446259)
24. S Bellentani G Bedogni L Miglioli C Tiribelli 2004 The epidemiology of fatty liver Eur J Gastroenterol Hepatol 16 1087 1093 10.1097/00042737-200411000- 00002 15489565 (Pubitemid 39488777)
25. JD Browning LS Szczepaniak R Dobbins P Nuremberg JD Horton JC Cohen, et al. 2004 Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology. 40 1387 1395 10.1002/hep.20466 15565570 (Pubitemid 39657013)
26. M Pan AI Cederbaum YL Zhang HN Ginsberg KJ Williams EA Fisher 2004 Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production J Clin Invest 113 1277 1287 15124019 1:CAS:528: DC%2BD2cXjvVOqsrc%3D
27. D Pessayre B Fromenty 2005 NASH: a mitochondrial disease J Hepatol 42 928 940 10.1016/j.jhep.2005.03.004 15885365 1:CAS:528:DC%2BD2MXktVGmtL8%3D (Pubitemid 40693212)
28. Z Yesilova H Yaman C Oktenli A Ozcan A Uygun E Cakir, et al. 2005 Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease Am J Gastroenterol 100 850 855 10.1111/j.1572-0241.2005.41500.x 15784031 1:CAS:528:DC%2BD2MXktFart74%3D (Pubitemid 40592378)
29. M Comporti B Arezzini C Signorini D Vecchio C Gardi 2009 Oxidative stress, isoprostanes and hepatic fibrosis Histol Histopathol 24 893 900 19475535 1:CAS:528:DC%2BD1MXhtVahsr3N (Review)
30. R Urtasun L Conde de la Rosa N Nieto 2008 Oxidative and nitrosative stress and fibrogenic response Clin Liver Dis. 12 769 790 10.1016/j.cld.2008.07. 005 18984466 1:STN:280:DC%2BD1cjhvVKisg%3D%3D (Review)
31. S Mahmood M Kawanaka A Kamei A Izumi K Nakata G Niiyama, et al. 2004 Immunohistochemical evaluation of oxidative stress markers in chronic hepatitis C Antioxid Redox Signal 6 19 24 10.1089/152308604771978318 14713333 1:CAS:528:DC%2BD2cXhs1ensw%3D%3D
32. O Niemelä 2007 Acetaldehyde adducts in circulation Novartis Found Symp 285 183 192 10.1002/9780470511848.ch13 17590995 (Review)
33. E Albano E Mottaran G Occhino E Reale M Vidali 2005 Review article: role of oxidative stress in the progression of non-alcoholic steatosis Aliment Pharmacol Ther 22 Suppl 2 71 73 10.1111/j.1365-2036.2005.02601.x 16225478 (Review)
34. C Eboumbou JP Steghens OM Abdallahi A Mirghani P Gallian A van Kappel, et al. 2005 Circulating markers of oxidative stress and liver fibrosis in Sudanese subjects at risk of schistosomiasis and hepatitis Acta Trop 94 99 106 10.1016/j.actatropica.2005.03.001 15814296 1:CAS:528:DC%2BD2MXktVOgs7c%3D (Pubitemid 40693093)
35. S Seki T Kitada H Sakaguchi 2005 Clinicopathological significance of oxidative cellular damage in non-alcoholic fatty liver diseases Hepatol Res. 33 132 134 10.1016/j.hepres.2005.09.020 16198621 1:CAS:528:DC%2BD2MXht1GnurjN (Pubitemid 41799790)
36. K Begriche A Igoudjil D Pessayre B Fromenty 2006 Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it Mitochondrion 6 1 28 10.1016/j.mito.2005.10.004 16406828 1:CAS:528: DC%2BD28XhsFyru7k%3D (Pubitemid 43250588)
37. A Berson V De Beco P Lettéron MA Robin C Moreau J El Kahwaji, et al. 1998 Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes Gastroenterology 114 764 774 10.1016/S0016-5085(98)70590-6 9516397 1:CAS:528:DyaK1cXisVWms7g%3D (Pubitemid 28160411)
38. KS Lee M Buck K Houglum M Chojkier 1995 Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression J Clin Invest 96 2461 2468 10.1172/JCI118304 7593635 1:CAS:528:DyaK28XltF2gtg%3D%3D
39. D Trinder OT Ayonrinde JK Olynyk 2008 HCV, iron, and oxidative stress: the new choreography of hepcidin Gastroenterology 134 348 351 10.1053/j.gastro.2007.11.048 18166363 1:CAS:528:DC%2BD1cXhtlehur0%3D (Pubitemid 350309353)
40. M Ono C Sekiya M Ohhira M Ohhira M Namiki Y Endo, et al. 1999 Elevated level of serum Mn-superoxide dismutase in patients with autoimmune cholangitis: possible involvement of free radicals in the pathogenesis in autoimmune cholangitis J Lab Clin Med 118 476 483
41. Y Kadokawa K Ohba K Omagari S Akazawa K Hayashida K Ohnita, et al. 2007 Intracellular balance of oxidative stress and cytoprotective molecules in damaged interlobular bile ducts in autoimmune hepatitis and autoimmune cholangitis: in situ detection of 8-hydroxydeoxyguanosine and glutathione-S-transferase-pi Hepatol Res 37 620 627 10.1111/j.1872-034X.2007. 00093.x 17517071 (Pubitemid 47009248)
42. TL Salunga ZG Cui S Shimoda HC Zheng K Nomoto T Kondo, et al. 2007 Oxidative stress-induced apoptosis of bile duct cells in autoimmune cholangitis J Autoimmun 29 78 86 10.1016/j.jaut.2007.04.002 17544621 1:CAS:528: DC%2BD2sXhtVCmurrN (Pubitemid 47385107)
43. F Farinati R Cardin N De Maria G Della Libera C Marafin E Lecis, et al. 1995 Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis J Hepatol 22 449 456 10.1016/0168-8278(95)80108-1 7545199 1:STN:280:DyaK2MzpsFagtQ%3D%3D
44. M Vidali G Occhino A Ivaldi C Rigamonti M Sartori E Albano 2008 Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C Am J Gastroenterol 103 1 147 153 18184121 1:CAS:528:DC%2BD1cXhsVyjt7o%3D
45. SF Stewart M Vidali CP Day E Albano DE Jones 2004 Oxidative stress as a trigger for cellular immune responses in patients with alcoholic liver disease Hepatology 39 1 197 203 10.1002/hep.20021 14752838 (Pubitemid 38461482)
46. E Albano 2002 Free radical mechanisms in immune reactions associated with alcoholic liver disease Free Radic Biol Med 15 110 114 10.1016/S0891-5849(01) 00773-0 (Pubitemid 34127699)
47. W Schneiderhan A Schmid-Kotsas J Zhao A Grünert A Nüssler H Weidenbach, et al. 2001 Oxidized low-density lipoproteins bind to the scavenger receptor, CD36, of hepatic stellate cells and stimulate extracellular matrix synthesis Hepatology 34 729 737 10.1053/jhep.2001.27828 11584369 1:CAS:528:DC%2BD3MXns1Kisrw%3D (Pubitemid 32927997)
48. O Viñas R Bataller P Sancho-Bru P Ginès C Berenguer C Enrich, et al. 2003 Human hepatic stellate cells show features of antigen-presenting cells and stimulate lymphocyte proliferation Hepatology. 38 919 929 14512879
49. SA Polyzos J Kountouras C Zavos 2009 Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines Curr Mol Med. 9 299 314 10.2174/156652409787847191 19355912 1:CAS:528:DC%2BD1MXktlant7o%3D
50. VA Arvaniti KC Thomopoulos A Tsamandas M Makri A Psyrogiannis G Vafiadis, et al. 2008 Serum adiponectin levels in different types of non alcoholic liver disease. Correlation with steatosis, necroinflammation and fibrosis Acta Gastroenterol Belg 71 355 360 19317274 1:STN:280:DC%2BD1M3jtVKitw%3D%3D
51. D van der Poorten J George 2008 Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis Clin Liver Dis 12 805 824 10.1016/j.cld.2008.07.003 18984468
52. J Jou SS Choi AM Diehl 2008 Mechanisms of disease progression in nonalcoholic fatty liver disease Semin Liver Dis 28 370 379 10.1055/s-0028- 1091981 18956293 1:CAS:528:DC%2BD1cXhsVKisr7M
53. Y Eguchi T Mizuta E Ishibashi Y Kitajima N Oza S Nakashita, et al. 2009 Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation Liver Int. 29 213 220 10.1111/j.1478-3231.2008.01853.x 18710430 1:CAS:528:DC%2BD1MXisV2rtbo%3D
54. C Bertolani F Marra 2008 The role of adipokines in liver fibrosis Pathophysiology. 15 91 101 10.1016/j.pathophys.2008.05.001 18602801 1:CAS:528:DC%2BD1cXpt1KjurY%3D
55. V Ratziu P Giral S Jacqueminet F Charlotte A Hartemann-Heurtier L Serfaty LIDO Study Group, et al. 2008 Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) trial Gastroenterology 135 100 110 10.1053/j.gastro.2008.03.078 18503774 1:CAS:528:DC%2BD1cXps1Wltrc%3D (Pubitemid 351916703)
56. MJ Burkitt RP Mason 1991 Direct evidence for in vivo hydroxyl-radical generation in experimental iron overload: an ESR spin-trapping investigation Proc Natl Acad Sci USA 88 8440 8444 10.1073/pnas.88.19.8440 1656444 1:CAS:528:DyaK3MXmtlWjsro%3D
57. MB Kadiiska MJ Burkitt QH Xiang RP Mason 1995 Iron supplementation generates hydroxyl radical in vivo. An ESR spin-trapping investigation J Clin Invest 96 1653 1657 10.1172/JCI118205 7657835 1:CAS:528:DyaK2MXnvVGqu7s%3D
58. K Houglum M Filip JL Witztum M Chojkier 1990 Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload J Clin Invest 86 1991 1998 10.1172/JCI114934 2123889 1:CAS:528: DyaK3MXlvF2ksA%3D%3D
59. A Pietrangelo F Borella G Casalgrandi G Montosi D Ceccarelli D Gallesi, et al. 1995 Antioxidant activity of silybin in vivo during long-term iron overload in rats Gastroenterology 109 1941 1949 10.1016/0016-5085(95)90762-9 7498660 1:CAS:528:DyaK28XlvFaltw%3D%3D
60. K Houglum GA Ramm DH Crawford JL Witztum LW Powell M Chojkier 1997 Excess iron induces hepatic oxidative stress and transforming growth factor β 1 in genetic hemochromatosis Hepatology 26 605 610 10.1002/hep.510260311 9303489 1:CAS:528:DyaK2sXmt1Cksbw%3D
61. A Pietrangelo R Gualdi G Casalgrandi G Montosi E Ventura 1995 Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents J Clin Invest 95 1824 1831 10.1172/JCI117861 7706489 1:CAS:528:DyaK2MXkslyktbo%3D
62. C Carter-Kent NN Zein AE Feldstein 2008 Cytokines in the pathogenesis of fatty liver and disease progression to steatohepatitis: implications for treatment Am J Gastroenterol 103 1036 1042 10.1111/j.1572-0241.2007.01709.x 18177455 1:CAS:528:DC%2BD1cXls1Cqtr4%3D (Pubitemid 351501089)
63. AM Diehl 2002 Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines Am J Physiol Gastrointest Liver Physiol 282 G1 G5 11751151 1:CAS:528: DC%2BD38XlsVKrug%3D%3D
64. O Cheung AJ Sanyal 2008 Abnormalities of lipid metabolism in nonalcoholic fatty liver disease Semin Liver Dis 28 351 359 10.1055/s-0028-1091979 18956291 1:CAS:528:DC%2BD1cXhsVKju7fE
65. P Letteron B Fromenty B Terris C Degott D Pessayre 1996 Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice J Hepatol 24 200 208 10.1016/S0168-8278(96)80030-4 8907574 1:STN:280:DyaK2s%2FmtlOjtQ%3D%3D (Pubitemid 26059117)